Abstract:Inflammatory bowel disease (IBD) has become a major health challenge worldwide. However, the precise etiological and pathophysiological factors involved in IBD remain unclear. Proteomics can be used for large-scale protein identification analysis. In the current study, using tandem mass tag- (TMT-) based shotgun proteomics, proteomic differences between intestinal tissue from health controls, patients with Crohn's disease (CD), and patients with ulcerative colitis (UC) were compared. Proteins with fold change >2 or <0.5 and P value < 0.05 between groups were considered differentially expressed. ProteinAtlas was used to analyze the tissue specificity of differentially expressed proteins (DEPs). Reactome pathway analysis was applied to cluster functional pathways. A total of 4786 proteins were identified, with 59 proteins showing higher levels and 43 showing lower levels in patients with IBD than in controls. Seventeen proteins, including angiotensin converting enzyme 2 (ACE2) and angiotensin converting enzyme 1 (ACE), showed higher levels in CD than in UC. Several novel proteins such as CD38, chitinase 3-like 1 (CHI3L1), olfactomedin 4 (OLFM4), and intelectin 1 were screened out between patients with IBD and controls. When proteins with fold change >1.2 or <0.84 and P value < 0.05 between groups were considered differentially expressed, the expression of 10 proteins, including CD38, involved in the nicotinamide adenine dinucleotide (NAD) metabolism and signaling pathway showed significant changes in IBD. Using the NCBI GEO database, we confirmed increased CD38 mRNA expression in patients with UC and in mouse colitis models. Protein CD38 expression was higher in CD and UC than in normal controls. CD38 expression was higher in inflamed tissues than in noninflamed tissues, and CD38 was located in F4/80-positive cells. Our study may provide novel insights into the molecular pathogenesis of IBD. Further studies are required on the role of NAD metabolism and CD38 in intestinal inflammation.

Unraveling the NAD Cyclizing and Calcium Signaling Functions of Human CD38

Structure and Enzymatic Functions of Human CD38.

The calcium signaling enzyme CD38 - a paradigm for membrane topology defining distinct protein functions

Crystal structure of human CD38 extracellular domain.

Determinants of the membrane orientation of a calcium signaling enzyme CD38.

Cyclic ADP-Ribose and NAADP: Structures, Metabolism and Functions

Resolving the Topological Enigma in Ca2+ Signaling by Cyclic ADP-ribose and NAADP

Structural Basis for Formation and Hydrolysis of the Calcium Messenger Cyclic ADP-ribose by Human CD38*

CD38–Cyclic ADP-Ribose Signal System in Physiology, Biochemistry, and Pathophysiology

Dynamic Conformations of the CD38-mediated NAD Cyclization Captured in a Single Crystal.

Conformational Closure of the Catalytic Site of Human Cd38 Induced by Calcium

Cytosolic CD38 Protein Forms Intact Disulfides and is Active in Elevating Intracellular Cyclic ADP-ribose*

Revealing CD38 Cellular Localization Using a Cell Permeable, Mechanism-Based Fluorescent Small-Molecule Probe

Covalent and Noncovalent Intermediates of an NAD Utilizing Enzyme, Human CD38

Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease.

Mechanism-based Small Molecule Probes for Labeling CD38 on Live Cells.

Formation and Hydrolysis of Cyclic Adp Ribose Catalyzed by Lymphocyte Antigen-Cd38

CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies

Catalysis-Based Inhibitors Of The Calcium Signaling Function Of Cd38

CD38: A Significant Regulator of Macrophage Function

Structural Basis for the Mechanistic Understanding of Human CD38-controlled Multiple Catalysis.